Introduction {#j_jvetres-2018-0027_s_001}
============

Pyrrolizidine alkaloids (PAs) are one of the most common groups of natural toxins. They are produced by a wide variety of plants as a chemical defence against herbivores ([@j_jvetres-2018-0027_ref_004]). Plants containing PAs often grow undesired in agricultural production systems, posing a risk of contamination of feeds and crops ([@j_jvetres-2018-0027_ref_009]). Bees often forage on the flowers of plants producing PAs, which leads to contamination of honey with the toxic compounds ([@j_jvetres-2018-0027_ref_006]).

The toxicity of PAs in humans is documented in a series of case reports of intoxication following ingestion of PAs containing herbal medicines and teas, and outbreak cases including deaths caused by the consumption of grain contaminated with PAs containing weeds ([@j_jvetres-2018-0027_ref_015]). However, not all PAs exert toxicity. Only 1,2-unsaturated alkaloids are pro-toxins which can be converted into toxic metabolites in the liver. The conversion is triggered by the cytochrome P450 monooxygenases located primarily in hepatocytes. As a result, reactive electrophilic pyrrolic metabolites capable of binding to proteins and nucleic acids are created ([@j_jvetres-2018-0027_ref_009], [@j_jvetres-2018-0027_ref_022]).

PAs can be a cause of acute and chronic intoxication. Acute poisoning with PAs in humans is more associated with liver damage ([@j_jvetres-2018-0027_ref_013]). In the case when the small amounts of dehydro PAs are regularly delivered *via* diet, cancer, pulmonary arterial hypertension, and cirrhosis are more likely to occur ([@j_jvetres-2018-0027_ref_010]).

Humans can ingest PAs unintentionally *via* consumption of various products. These toxic compounds can be consumed with grains contaminated with PA-producing plants, vegetable harvests with similar-looking weeds (*e.g* ragwort), herbal preparations, teas, honey, pollen contaminated with PAs ([@j_jvetres-2018-0027_ref_004]) and other food such as milk or eggs ([@j_jvetres-2018-0027_ref_026], [@j_jvetres-2018-0027_ref_027]).

Even though the toxicity of PAs has been well documented and high concentrations of PAs have been detected in various products, there is no official limit for the maximum allowable level of PAs in food and feed.

In Poland the production of honey is systematically increasing. The same trend can be observed in its consumption. Honey is consumed in its pure form or as an ingredient of breakfast cereals, sweets, or baked products. However, it has been proved that honey can be contaminated with PAs, and in some cases, high concentration of the alkaloids have been detected ([@j_jvetres-2018-0027_ref_001], [@j_jvetres-2018-0027_ref_003], [@j_jvetres-2018-0027_ref_007], [@j_jvetres-2018-0027_ref_008], [@j_jvetres-2018-0027_ref_019], [@j_jvetres-2018-0027_ref_022]). To increase consumer protection by minimising dietary exposure to these toxins, it was suggested that all honeys need to be assessed for their content of PAs ([@j_jvetres-2018-0027_ref_008], [@j_jvetres-2018-0027_ref_011], [@j_jvetres-2018-0027_ref_028]). In a European Food Safety Authority (EFSA) report it was suggested that new and sensitive analytical methods enabling PAs determination should be developed ([@j_jvetres-2018-0027_ref_013]).

Hitherto, different analytical methods have been described for the determination of PAs in honey. Most of them were based on the LC-MS/MS analysis and for the purification of extracts mostly cation exchange cartridges were used combined with ammonia in methanol elution of PAs. However, the purification of the extracts is not efficient, especially when LC-MS is used for the instrumental analysis, and many problems concerning the appropriate identification and quantification of PAs can occur. That is why a new sensitive analytical method providing effective clean-up of honey extracts has been developed.

Based on the EFSA recommendations and on the results of the occurrence of PAs in honey of European origin reported by other authors ([@j_jvetres-2018-0027_ref_008], [@j_jvetres-2018-0027_ref_013], [@j_jvetres-2018-0027_ref_017], [@j_jvetres-2018-0027_ref_025]), the ten most often detected alkaloids were selected for the study. The compounds designated were Senecionine-type PAs: jacobine, retrorsine, senecionine, and seneciphylline; Lycopsamine-type PAs: lycopsamine, intermedine, and echimidine; and Heliotrine-type PAs: heliotrine and lasiocarpine. Senkirkine was also included, as it was found that together with echimidine, echimidine *N*-oxide, heliotrine, lycopsamine, retrorsine, senecionine, and seneciphylline it constituted around 75%--90% of the total PAs measured in honey ([@j_jvetres-2018-0027_ref_014]). The *N*-oxides are reduced with the zinc dust, hence the final determined concentration reflects the content of both free base and *N*-oxide forms.

Material and Methods {#j_jvetres-2018-0027_s_002}
====================

**Chemicals and reagents** Formic acid and zinc dust were from Sigma-Aldrich (USA), ethyl acetate and triethylamine were Merck (Germany) products, and methanol and acetonitrile were from the J.T. Baker catalogue (the Netherlands). Sulphuric acid (95%) was purchased from Chempur (Poland) and 25% ammonia solution was sourced from POCH (Poland). The Milli-Q water purification system (Millipore, USA) was used to obtain pure water. Oasis MCX solid phase extraction (SPE), mixed-mode polymeric cartridges were from Waters (USA), Bond Elut Plexa PCX and HF Bond Elut--SCX cartridges came from Agilent (USA), and Strata SCX and polymeric Strata XC cartridges were ordered from Phenomenex (USA). All cartridges were of 500 mg bed weight and 6 ml volume. Analytical standards of intermedine, lycopsamine, jacobine, retrorsine, heliotrine, seneciphylline, senecionine, echimidine, senkirkine, lasiocarpine, *N*-oxides of senecionine, echimidine and retrorsine were purchased from PhytoLab (Germany).

**Standard solutions** Stock standard solutions of intermedine, lycopsamine, jacobine, retrorsine, heliotrine, seneciphylline, senecionine, echimidine, senkirkine, lasiocarpine and were prepared at a concentration of 1 mg mL^−1^ in methanol and stored at −18°C. A mixed standard solution of 1 μg mL^−1^ was prepared by mixing the appropriate volume of each stock standard solution and subsequently diluting serially. The mixed standard solution was stored between 2 and 4°C.

**Honey samples** The honey samples were from Poland and were collected directly from apiaries in 2017. The honey analysed included polyfloral, acacia, rape, and honeydew. Part of the samples were of unknown type.

**Sample preparation** 10 g of homogenised honey was weighed into a 50 mL polypropylene tube and dissolved in 20 mL of 0.05 M sulphuric acid. About 1 g of zinc dust was added to reduce *N*-oxides, and samples were left overnight. On the next day, the samples were slowly shaken for 0.5 h, subsequently centrifuged (4,000 *g*, 10 min) and passed through cellulose filters, then purified with the use of solid phase extraction. The samples were applied on MCX cartridges preconditioned with 9 mL of methanol and equilibrated with 9 mL of 0.05 M H~^2^~SO~^4^~. A total of 12 mL of H~^2^~O and 12 mL of MeOH were used for washing purposes, subsequently cartridges were vacuum dried for 2 min, and 6 mL of ethyl acetate were added. The elution of the alkaloids was done with 12 mL of solvent mixture consisting of ethyl acetate, methanol, acetonitrile, ammonia, and triethylamine (8:1:1:0.1:0.1 v/v). After evaporation at 40°C in a nitrogen stream the residues were reconstituted in 0.2 mL of water and 0.2 mL of methanol and passed through 0.2 μm PVDF syringe filters.

**LC-MS parameters** HP 1200 Series separation modules from Agilent Technologies (USA) were used for the instrumental analysis. The modules included a degasser system, binary pump, automatic injector, column thermostat, and single quadrupole mass spectrometry detector (Agilent Technologies 6140). The alkaloids were separated on a Gemini 3 μm NX-C18, 150 mm × 4.6 mm column, (Phenomenex, USA) coupled with a C18 guard column (Phenomenex). The column thermostat was set at 30°C. The separation of the compounds was carried out in a gradient mode: 0--2 min, 5.5% B; 2--8 min, 12% B; 8--11 min, 20% B; 11--12 min, 30% B; 12--15 min, 40% B; 17-16 min, 70% B; 16--17 min, 85% B; and 17--23 min, 5.5% B. The mobile phase consisted of 0.2% formic acid in water (A) and a mixture of methanol and acetonitrile (1:1, v/v) (B). The flow rate was 0.6 mL min^-1^ and the injection volume was 5 μL.

Electrospray ionisation (ESI) was in a positive mode, the capillary voltage was set at 2,000 V, nebulising pressure was 35 psi, drying gas flow was set at 11.0 L min^−1^, and temperature of drying gas was 300°C. The fragmentor voltage was set at 100 V for all target alkaloids, and selected ion monitoring was used for the detection. Monitored, protonated molecular (M+H)^+^ ions (m/z) are listed in [Table 1](#j_jvetres-2018-0027_tab_001){ref-type="table"}.

###### 

Selected (m/z) ions monitored and retention times of the monitored alkaloids. Coefficients of determination obtained for matrix calibration curves in a concentration range corresponding to 0--50 μg kg^---1^ and matrix effect results

  PA               m/z     RT      R^2^    ME (%)
  ---------------- ------- ------- ------- --------
  Intermedine      300.1   6.16    0.997   105.5
  Lycopsamine      300.0   6.38    0.99    116.5
  Jacobine         352.1   6.91    0.998   119.2
  Retrorsine       352.1   8.31    0.998   117.4
  Heliotrine       314.1   8.63    0.998   119.9
  Seneciphylline   334.1   9.33    0.998   119.2
  Senecionine      336.1   11.14   0.994   122.6
  Echimidine       398.0   13.18   0.998   117.1
  Senkirkine       366.1   13.37   0.995   106.2
  Lasiocarpine     412.1   15.11   0.996   107.5

PA -- pyrrolizidine alkaloid, RT -- retention time, R^2^ -- coefficient of determination, ME -- matrix effect

**Identification and quantification** Identification was made on the basis of retention time and the protonated molecular ion (M+H)^+^ of monitored compounds.

Quantification was achieved using matrix calibration curves prepared by adding appropriate amounts of mixed reference standard solutions to blank honey before the extraction procedure. Calibration curves at the concentration range 0--50 μg kg^--1^ were constructed by plotting the pyrrolizidine alkaloid (PA) peak area *versus* its concentrations.

**Method validation** The validation of the method was performed according to the SANTE/11945/2015 guidance document ([@j_jvetres-2018-0027_ref_029]). Parameters such as method linearity, recovery, repeatability, reproducibility, specificity, limit of quantification (LOQ), robustness, stability of PAs, and matrix effect were evaluated during the validation process. Buckwheat honey was used as the blank matrix, as no alkaloids were determined in this type of honey.

For evaluation of the linearity of the method, matrix calibration curves were used. Blank honey samples before the extraction treatment were fortified with the mix standard solution to obtain appropriate concentrations corresponding to 0, 1, 2, 5, 10, 20, and 50 μg kg^--1^, and were analysed in triplicate.

To evaluate the method\'s recovery and precision, honey blanks were spiked at different levels corresponding to the concentrations 1, 10, and 50 μg kg^--1^, with a set of six samples for each level. The samples were analysed with the same instrument and by the same operator. The relative standard deviation of the results (RSD) (%) was assigned as the expression of the repeatability. For the determination of reproducibility, other sets of samples were spiked at the same concentrations as for repeatability and analysed on different days with the same instrument. The reproducibility was also calculated as relative standard deviation (%).

For the selectivity determination, an analysis of a set of blank honey samples was performed in order to check the presence of interfering compounds.

The limit of quantification was established on the basis of the SANTE guidance document ([@j_jvetres-2018-0027_ref_029]), according to which the LOQ was assumed to be the lowest spike level meeting the method performance criteria for trueness and precision.

Matrix effect was evaluated by dividing a slope of matrix-matched calibration by a slope of standard calibration in solvent and expressing the result as a percentage.

A stability test was performed on purified extracts of honey blanks that were contaminated at 20 μg kg^--1^ before the extraction procedure. The dry extracts were stored at −18ºC, 4ºC, and 20ºC. The extracts were subsequently analysed on days 1, 2, 4, 8, 14, and 30.

To determine the robustness of the method, the Youden procedure was applied ([@j_jvetres-2018-0027_ref_030]). Blank honey samples fortified at the concentration of 20 μg kg^--1^ were analysed in order to evaluate the effect of the seven chosen variables which were altered. The effect of percentage of sulphuric acid (0.05 M and 0.1 M), volume of elution mixture (12 mL and 10 mL), temperature of evaporation (40ºC and 45ºC), percentage of methanol in the mobile phase (50% and 47%), percentage of acetonitrile in the mobile phase (50% and 47%), thermostat temperature (30ºC and 33ºC), and flow rate (0.6 mL min^--1^ and 0.57 mL min^--1^) were evaluated. Student\'s *t*-test was used to determine the impact of changes in individual parameters on the results.

Results {#j_jvetres-2018-0027_s_003}
=======

**Validation results** Good linearity over the concentration range 0--50 μg kg^−1^ was observed for the target PAs. The determination coefficients R^2^ calculated for each of the matrix calibration curves were equal or greater than 0.99 ([Table 1](#j_jvetres-2018-0027_tab_001){ref-type="table"}). Matrix effect was noticeable in the case of most of the analysed alkaloids, especially for jacobine, heliotrine, seneciphylline, echimidine, and senecionine ([Table 1](#j_jvetres-2018-0027_tab_001){ref-type="table"}).

Validation parameters ([Table 2](#j_jvetres-2018-0027_tab_002){ref-type="table"}) were determined on the basis of analysis of sets of blank honey samples spiked at the levels corresponding to concentrations 1, 10, and 50 μg kg^−1^. Obtained recovery values were from 80.6% to 114.5%. The repeatability was calculated as relative standard deviation and ranged from 2.3% to 14.6%, and the reproducibility was in the range of 4.9% to 17.7%. The method can be perceived to be selective, as no interfering peaks were determined in the retention time of the selected alkaloids ([Fig. 1](#j_jvetres-2018-0027_fig_001){ref-type="fig"}).

![SIM chromatograms of honey samples obtained for a) HF Bond cartridge and 3% ammonia in methanol elution (PAs concentration 1 μg kg^−1^); b) MCX cartridge and new elution mixture consisting of ethyl acetate, methanol, acetonitrile, ammonia, and triethylamine (8:1:1:0.1:0.1, v/v) elution (PAs concentration 1 μg kg^−1^); c) blank sample\
Int -- Intermedine, Lyc -- lycopsamine, Jcb -- jacobine, Ret -- retrorsine, Hel -- heliotrine, Snc -- seneciphylline, Sen -- senecionine, Ech -- echimidine, Skn -- senkirkine, Las -- lasiocarpine](jvetres-62-173-g001){#j_jvetres-2018-0027_fig_001}

###### 

Validation parameters evaluated for ten alkaloids in honey matrix

                           Concentration level (μg kg^--1^)                  Concentration level (μg kg^--1^)                Concentration level (μg kg^--1^)   
  ---------------- ------- ---------------------------------- ------- ------ ---------------------------------- ----- ------ ---------------------------------- ------
  Intermedine      80.6    84.6                               96.3    14.6   6.0                                5.4   17.7   16.6                               10.1
  Lycopsamine      108.2   97.4                               100.6   11.1   9.1                                2.5   16.3   9.2                                7.1
  Jacobine         90.7    99.3                               97.5    10.9   9.7                                4.5   15.2   11.5                               4.9
  Retrorsine       98.2    105.5                              98.6    13.6   5.2                                7.5   16.8   7.3                                8.5
  Heliotrine       80.9    101.4                              95.6    8.5    4.0                                4.3   15.0   7.3                                5.1
  Seneciphylline   108.1   101.5                              111.6   7.3    5.3                                2.5   12.8   11.2                               15.6
  Senecionine      87.2    106.9                              102.4   7.5    7.2                                2.3   10.3   11.2                               7.6
  Echimidine       103.9   109.4                              114.5   8.1    5.6                                6.6   15.2   17.0                               13.0
  Senkirkine       88.0    104.5                              100.5   9.1    2.9                                4.4   11.8   9.5                                5.3
  Lasiocarpine     82.2    108.9                              105.6   2.9    12.4                               3.1   12.1   12.5                               7.9

The robustness test revealed that chosen variables do not affect the analysis. The calculated standard deviation was not significantly higher than the standard deviation of the method carried out under within-laboratory reproducibility conditions. To determine the impact of changes in individual parameters on the result of the analysis, Student\'s *t*-test was used and no significant statistical differences were determined. Changes in composition of the mobile phase did not affect the retention times; however, slight shifts could be observed with higher thermostat temperature and lower flow rate.

The stability test revealed that dry extracts of honey can be stored at −18°C and 4°C for a week without a significant change in PAs concentrations [Fig. 2](#j_jvetres-2018-0027_fig_002){ref-type="fig"}, data shown only for −18°C).

![Stability results of the target PAs in dry SPE-purified extracts of honey matrix, stored at −18°C for 30 days](jvetres-62-173-g002){#j_jvetres-2018-0027_fig_002}

The limit of quantification of the developed method for the determination of PAs in honey was established at 1 μg kg^−1^ for all individual alkaloids, as it was the lowest spiked level with the recovery and precision values that were in the range fixed in the SANTE guidance document ([Table 2](#j_jvetres-2018-0027_tab_002){ref-type="table"}).

**Real samples application** The developed method has been applied to the analysis of 50 honey samples. Within the samples, 16 (32%) were contaminated with at least one of the alkaloids, however, in five samples the determined concentrations were below LOQ ([Fig. 3](#j_jvetres-2018-0027_fig_003){ref-type="fig"}). In five samples more than one alkaloid was found. Among detected PAs, echimidine was the most abundant alkaloid, being present in 43.8% of the positive samples in the concentration range of 1.4--5.2 μg kg^−1^ ([Table 3](#j_jvetres-2018-0027_tab_003){ref-type="table"}). Lycopsamine and intermedine were detected in 31.3% and 25% of the positive honey samples, respectively. Retrorsine was detected in 25% and senecionine was present in 18.8% of all positive samples.

![The content of pyrrolizidine alkaloids in positive honey samples](jvetres-62-173-g003){#j_jvetres-2018-0027_fig_003}

###### 

Summary of detected PAs

  PA            Number of samples   Mean concentration (μg kg^--1^)   Median (μg kg^--1^)   Min.-Max content (μg kg^--1^)
  ------------- ------------------- --------------------------------- --------------------- -------------------------------
  Intermedine   4                   4.8                               1.9                   \<LOQ--14.7
  Lycopsamine   5                   9.4                               3.0                   1.7--32.9
  Retrorsine    4                   1.1                               1.2                   \< LOQ--1.8
  Senecionine   3                   1.0                               \<LOQ                 \< LOQ--2.9
  Echimidine    7                   3.3                               3.8                   1.4---5.2

The total content of alkaloids in particular samples ranged from 1.4 to 52.4 μg kg^−1^ ([Fig. 3](#j_jvetres-2018-0027_fig_003){ref-type="fig"}). The mean and median values (calculated for PA positive samples and without values \<LOQ) were 8.6 and 4.1 μg kg^−1^, respectively. When all samples were included into the calculations, the mean concentration was 2.0 μg kg^−1^.

Discussion {#j_jvetres-2018-0027_s_004}
==========

**Method development and validation** Honey is considered a difficult and complex matrix of variable composition. The ratio of different substances such as proteins, minerals, organic acids, *etc*. can be influenced by the plant source and other factors such as seasonal and environmental conditions ([@j_jvetres-2018-0027_ref_012]). Additionally, the fact that PAs can occur in very low concentrations poses a challenge as far the analysis of the compounds is concerned.

During the development of this LC-MS method various parameters were optimised to deliver the most effective performance in recovery, precision, and chromatographic separation. Even though the *N*-oxides can be directly determined using liquid chromatography, it was decided to reduce them to their free base form. As in the case of a previous gas chromatography-mass spectrometry method ([@j_jvetres-2018-0027_ref_021]), the influence of the reduction reaction was also revealed in the purer chromatographic image. Reduction time was optimised with the use of three *N*-oxides: retrorsine, senecionine, and echimidine. The reduction efficiency was checked for 1.5, 2, 3, 4, 5, and 24 h. Almost 100% conversion of *N*-oxides of senecionine and echimidine and over 80% conversion of retrorsine *N*-oxide was achieved after the 24 h reduction period.

For the clean-up of basic amine compounds from complex matrices, cation exchange sorbents have been widely used. Cation exchange SPE cartridges were the choice of most of the authors describing determination of PAs in honey. They also used ammonia solution of different concentrations in methanol for the elution of PAs from the cartridges and LC-MS/MS for the instrumental analysis ([@j_jvetres-2018-0027_ref_002], [@j_jvetres-2018-0027_ref_003],[@j_jvetres-2018-0027_ref_005], [@j_jvetres-2018-0027_ref_008], [@j_jvetres-2018-0027_ref_018], [@j_jvetres-2018-0027_ref_020], [@j_jvetres-2018-0027_ref_022], [@j_jvetres-2018-0027_ref_023]). However, the eluate was not always properly purified, which could lead to problems such as ion suppression or enhancement or erroneous identification of the target compounds. Moreover, in the case of LC-MS analysis, the identification of the alkaloids at low concentrations was impossible when ammonia in methanol was used for PAs elution.

In the previously conducted study, a new elution mixture consisting of ethyl acetate, methanol, ammonia and triethylamine (8:2:0.1:0.1, v/v) was developed for the PAs elution from cation exchange cartridges ([@j_jvetres-2018-0027_ref_021]). As the technique has been changed, the SPE clean-up procedure had to be re-optimised. The optimisation was performed to investigate the impact of the previously developed and modified elution mixture ([Table 4](#j_jvetres-2018-0027_tab_004){ref-type="table"}) on the purification of honey extracts along with the recovery of 10 alkaloids using different cation exchange SPE sorbents: MCX, PCX, Strata XC, SCX, and HF Bond.

###### 

Combinations of solvents used during optimisation of solid phase extraction step. Recovery rates obtained for target alkaloids at the concentration of 20 μg kg^--1^

  Solvents                            Ratio (v/v)                Recovery (%)
  ----------------------------------- -------------------------- --------------
  EtAc : MeOH : NH^4^OH               8 : 2 : 0.2                77--93
  EtAc : MeOH : NH^4^OH : TEA         8 : 2 : 0.1 : 0.1          84--98
  EtAc : MeOH : ACN : NH^4^OH : TEA   8: 1 : 1 : 0.1 : 0.1       79--105
  EtAc : MeOH : ACN : NH^4^OH : TEA   7: 1.5 : 1.5 : 0.1 : 0.1   78--92
  EtAc : MeOH : ACN : NH^4^OH : TEA   8 : 1 : 1 : 0.2 : 0.1      76--97
  EtAc : MeOH : ACN : NH^4^OH : TEA   3 : 3 : 3 : 0.1 : 0.1      61--93
  MeOH : NH^4^OH                      11 : 1.5                   48--110

EtAc -- ethyl acetate, MeOH -- methanol, ACN -- acetonitrile, NH^4^OH -- ammonia solution, TEA -- triethylamine

In general, comparable recoveries were obtained for most of the solvents mixtures. However, the purity of the chromatograms was also a very important factor influencing the choice of the final elution mixture and SPE cartridge. An increased volume of MeOH or NH^4^OH caused increased elution of impurities, which affected the quality of the chromatograms, whereas the introduction of 1 mL of acetonitrile into the elution mixture and a decrease in the volume of methanol allowed very pure chromatograms to be obtained. As far as the cartridges are concerned, good recovery rates were obtained with MCX, PCX, and SCX cartridges ([Fig. 4](#j_jvetres-2018-0027_fig_004){ref-type="fig"}). In the case of HF cartridge, intermedine and lycopsamine were recovered to much lower extents. Cartridges such as SCX, Strata XC, and PCX caused additional problems related to clogging and prolonging the time of SPE procedure. A much worse purification effect was obtained with PCX and Strata XC comparing to other cartridges.

![Recoveries of the alkaloids from different SPE cartridges eluted with the new solvents mixture consisting of ethyl acetate, methanol, acetonitrile, ammonia, and triethylamine (8:1:1:0.1:0.1, v/v)](jvetres-62-173-g004){#j_jvetres-2018-0027_fig_004}

The best results concerning recoveries of target compounds and purity of chromatograms were obtained with the elution mixture consisting of ethyl acetate, methanol, acetonitrile, ammonia, and triethylamine (8:1:1:0.1:0.1 v/v) in combination with MCX cartridges.

For comparison purposes and to highlight the efficiency of clean-up with the new elution mixture and MCX cartridge, the results of purification obtained with HF Bond cartridge and 3% ammonia solution in methanol have been presented in [Fig. 1](#j_jvetres-2018-0027_fig_001){ref-type="fig"}. The HF cartridge was chosen for the comparison as it was often used by other authors ([@j_jvetres-2018-0027_ref_003], [@j_jvetres-2018-0027_ref_007], [@j_jvetres-2018-0027_ref_008], [@j_jvetres-2018-0027_ref_020]).

To achieve the best chromatographic performance different columns and mobile phases of variable composition were evaluated. The chromatographic columns assessed were Zorbax XDB C18, 150 mm × 4.6 mm, 5 μm (Agilent); Gemini NX-C18 150 mm × 4.6 mm, 3 μm (Phenomenex); Kinetex C8, 100 mm × 4.6 mm, 2.6 μm (Phenomenex); and Zorbax ODS C18, 250 mm × 4.6 mm, 5 μm (Agilent). Tested combinations of mobile phases included: 0.1%--0.5% formic acid in water (A) with ACN (B); 0.1%--0.5% formic acid in water (A) with MeOH (B); 0.1%--0.5% formic acid in water (A) with ACN:MeOH (1:1, v/v) (B); 0.1%--0.3% formic acid in water (A) with 0.1%--0.3% formic acid in ACN (B); and 0.1%--0.3% formic acid in water (A) with 0.1%--0.3% formic acid in MeOH (B). However, none of the combinations of mobile phases containing only methanol or only acetonitrile as the organic phase allowed good separation of the analysed compounds. The separation of 10 alkaloids including two enantiomeric structures of intermedine and lycopsamine that usually co-elute, was achieved with a Gemini NX-C18 column and mobile phase consisting of 0.2% formic acid in water (A) and a mixture methanol:acetonitrile (1:1, v/v) (B), ([Fig. 1](#j_jvetres-2018-0027_fig_001){ref-type="fig"}). Parameters affecting the mass spectrometry detection were optimised with the use of flow injection analysis.

The method was successfully validated according to the stipulations of the SANTE/11945/2015 guidance document ([@j_jvetres-2018-0027_ref_029]). The method proved to be linear in the concentration range 0--50 μg kg^−1^ and selective as no interfering peaks were determined in the retention times of monitored alkaloids. The recovery was in the range of 80.6%--114.5%, which was in compliance with SANTE requirements, according to which the recovery should be in the range of 70%--120%. The obtained results were also comparable with recoveries obtained by other authors. Lucatello *et al* ([@j_jvetres-2018-0027_ref_022]) reported recoveries ranging from 82.7% to 104.2% and Griffin *et al* ([@j_jvetres-2018-0027_ref_018]) obtained recoveries in a range of 82%--112%. Recoveries reported by Martinello *et al* ([@j_jvetres-2018-0027_ref_024]) ranged from 92% to 115%. Some authors reported slightly lower rates of recoveries ranging from 70% to 90% ([@j_jvetres-2018-0027_ref_001],[@j_jvetres-2018-0027_ref_003]). Repeatability and reproducibility values were below 20% and were in the ranges of 2.3%--14.6% and 4.9%--17.7%, respectively. Other authors reported similar values. Bodi *et al* ([@j_jvetres-2018-0027_ref_003]) obtained values 2%--13% and 2%--11%, Lucatello *et al* ([@j_jvetres-2018-0027_ref_022]) obtained 0.8%--7.9% and 3.1%--14.2%, Griffin *et al* ([@j_jvetres-2018-0027_ref_018]) reported 1.1%--6.3% and 2.0%--14.9%, and Martinallo *et al* ([@j_jvetres-2018-0027_ref_024]) reported ranges of 0.9%--15.1% and 1.1%--15.6% for repeatability and reproducibility, respectively.

The developed method proved to be robust to small changes in performance parameters. The matrix effect was noticeable for most of the analysed compounds as it was almost 120%, and in the case of senecionine exceeded this value.

According to an EFSA report of 11 July, 2012 ([@j_jvetres-2018-0027_ref_016]), the relevant LOQ to be achieved for the individual PAs in honey was 1 μg kg^−1^. The limit of quantification of the developed method for the determination of PAs in honey was established at 1 μg kg^−1^ for all individual alkaloids, which fulfils the requirements. Obtained LOQ values for the developed LC-MS method are also very comparable or even lower than these reported by other authors for LC-MS/MS methods which ranged from 1 to 68.0 μg kg^−1^ for the individual alkaloids ([@j_jvetres-2018-0027_ref_017],[@j_jvetres-2018-0027_ref_018],[@j_jvetres-2018-0027_ref_020],[@j_jvetres-2018-0027_ref_023],[@j_jvetres-2018-0027_ref_028]).

**Real sample analysis** The lycopsamine-type alkaloids echimidine, lycopsamine, and intermedine were the most often detected, while senecionine-type PAs had slightly lower incidence rates, which is consistent with results reported for EU honey by Huybrechts and Callebaut (19). Also, Dübecke *et al* ([@j_jvetres-2018-0027_ref_008]), Griffin *et al* ([@j_jvetres-2018-0027_ref_017]), and Martinello *et al* ([@j_jvetres-2018-0027_ref_024],[@j_jvetres-2018-0027_ref_025]) reported that among detected PAs in EU honey, the most abundant alkaloids were echimidine and lycopsamine. The obtained results are also in line with an EFSA report published in 2016. In the report it was concluded that echimidine and lycopsamine were the most important PAs in terms of contribution to the levels of PAs in honey, followed by senecionine and intermedine.

Most of the analysed monofloral honeys were free of PAs, and the highest determined concentration of 52.4 μg kg^−1^ was found in polyfloral honey sample ([Fig. 3](#j_jvetres-2018-0027_fig_003){ref-type="fig"}). The concentrations of detected alkaloids in Polish honey samples are also consistent with the results of other authors reporting PA contamination in honey of European origin. The content of PAs in honey reported by the authors was in a range of 0.6--43 μg kg^−1^, excluding significantly higher concentrations in honey from Italy and Spain ([@j_jvetres-2018-0027_ref_003],[@j_jvetres-2018-0027_ref_008],[@j_jvetres-2018-0027_ref_018],[@j_jvetres-2018-0027_ref_022],[@j_jvetres-2018-0027_ref_025],[@j_jvetres-2018-0027_ref_028]). The results also concur with previously conducted studies concerning the occurrence of PAs in Polish honey. The mean concentration and median for all samples were 2.9 and 1.6 μg kg^−1^, respectively ([@j_jvetres-2018-0027_ref_021]). However, the percentage of positive samples was higher at 68% compared to the 32% for this study. This could be caused by the different rates of contamination with PAs that often depend on the particular year of honey production or by the fact that GC-MS sum parameter method detects almost all 1,2-unsaturated PAs, while in the case of LC-MS method some PAs can remain undetected.

For the assessment of the safety of the detected PAs concentration in honey for the consumers, usually an average adult weight of 60 kg and an average child weight of 15 kg, an average consumption of 20 g, and a recommended maximum intake of PAs in the amount of 0.007 μg kg^−1^ of body weight (b.w.) per day are taken into consideration. The maximum intake of PAs has been proposed by EFSA, the Committee on Toxicity and the Federal Institute of Risk Assessment. The level was calculated according to a BMDL^10^ (the lower confidence limit on the benchmark dose associated with 10% response) of 73 μg kg^−1^b.w. per day that was the result of a carcinogenicity study of lasiocarpine in rats, and with the MOE (margin of exposure) of 10,000.

Considering the above, adults can have a maximum daily intake of PAs of 0.42 μg, and children's maximum PAs daily intake should not exceed 0.105 μg. Thus, the maximum concentration in honey should not exceed 21 μg kg^−1^ for adults and 5.25 μg kg^−1^ for children. However, in the case of children the average consumption of 20 g may be somewhat overestimated. That is why data provided in the EFSA report ([@j_jvetres-2018-0027_ref_014]) were taken for the calculation of allowable content of PAs in honey. In the young honey-consuming population, the average habitual consumption of honey has been evaluated as 0.98 g kg^−1^ b.w. per day. In that case, the maximum content of PAs in honey should not exceed 7.1 μg kg^−1^.

Amongst the analysed honey samples, only one would exceed the limit of recommended daily intake if consumed in the amount of 20 g or higher, in an adult diet. Other positive samples had relatively low PAs concentrations ranging from 1.4 to 9.7 μg kg^−1^ and can be regarded as safe under the 20 g consumption amount. In a child diet, two samples would exceed the limit of PAs content of 7.1 μg kg^−1^.

However, in an EFSA report from 2017, the CONTAM Panel selected the BMDL^10^ of 237 μg kg^−1^ b.w. per day, determined on the basis of incidence of liver haemangiosarcoma in female rats exposed to riddelliine ([@j_jvetres-2018-0027_ref_015]). Using the new BMDL^10^ the maximum intake can be calculated as three times higher than the previous one. Consequently, the concentration of PAs in honey can also be three times higher, which would be 71.1 μg kg^−1^ and 24.2 μg kg^−1^ for adults and children, respectively, and still be treated as safe. With these limits, no PA-positive honeys would exceed the recommended limit of daily intake by adults in their 20 g per day consumption, and only one honey would pose a potential risk to children.

In conclusion, a sensitive and selective method suitable for determination of PAs in honey has been developed. The method has been validated according to the SANTE/11945/2015 guidance document, and all evaluated parameters are in agreement with the requirements. For these reasons the developed method can be perceived as a useful tool for the analysis of selected PAs in honey in routine laboratory practice. The method has been applied to the analysis of 50 honey samples. Among analysed samples 32% were positive for the presence of at least one of the alkaloids. Echimidine, lycopsamine, and intermedine were the most abundant among detected alkaloids. On the basis of the detected PAs concentrations it can be stated that most of the analysed honey samples should not pose any potential risk to the consumers.
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